NCT03741764View on ClinicalTrials.gov

Treatment of Dupuytren's Disease With Minimal Invasive Surgery and VIVOSORB® Resorbable Implant Device

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Dupuytren ContractureDupuytren Disease of Palm and Finger

Interventions

DEVICE

Vivosorb

Resorbable implant device

Trial Locations (1)

3212

UZ Leuven, campus Pellenberg, Pellenberg

All Listed Sponsors

lead

prof. dr. Ilse Degreef

OTHER

NCT03741764 - Treatment of Dupuytren's Disease With Minimal Invasive Surgery and VIVOSORB® Resorbable Implant Device | Biotech Hunter | Biotech Hunter